title: Case of coexisting psoriatic arthritis and bullous pemphigoid improved by etanercept.
authors.forename: Megumi
authors.initials: M
authors.lastname: Nin
authors.forename: Daisaku
authors.initials: D
authors.lastname: Tokunaga
authors.forename: Norito
authors.initials: N
authors.lastname: Ishii
authors.forename: Ayako
authors.initials: A
authors.lastname: Komai
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
authors.forename: Norito
authors.initials: N
authors.lastname: Katoh
mesh_terms: D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D001324:Autoantigens / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D000068800:Etanercept; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D024041:Non-Fibrillar Collagens / Q000378:metabolism; D010391:Pemphigoid, Bullous / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016896:Treatment Outcome; D000097805:Collagen Type XVII
chemical_list: D001324:Autoantigens; D015415:Biomarkers; D000068800:Etanercept; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D024041:Non-Fibrillar Collagens; D018124:Receptors, Tumor Necrosis Factor; D000097805:Collagen Type XVII